Prevalence of Novel Psychoactive Substance (NPS) Use in Patients Admitted to Drug Detoxification Treatment
Bibliographic Data
| ID | 15517500 |
|---|---|
| Authors | Michael Specka (0000-0001-5194-7876, University of Duisburg-Essen, corresponding author), Thomas Kuhlmann (Federal Highway and Transport Research Institute), Jürgen Sawazki (LVR-Klinik für Orthopädie Viersen), Udo Bonnet (0000-0002-2592-8337, Rütgers (Germany)), Renate Steinert (Landschaftsverband Westfalen-Lippe), Monika Cybulska-Rycicki (Asklepios Klinik Langen), Helmut Eich (Kliniken Maria Hilf), Benita Zeiske, Antje Niedersteberg (Krankenhaus Düren), Luzia Schaaf (LVR-Klinik für Orthopädie Viersen), Norbert Scherbaum (0000-0003-1759-6990, University of Duisburg-Essen) |
| Year | 2020 |
| Volume | 11 |
| Pages | 569-569 |
| Publication date | 2020-07-07 |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Frontiers in Psychiatry (JOURNAL) |
| Journal identifiers | ISSN: 1664-0640 • E-ISSN: 1664-0640 |
| Publisher | Frontiers Media (PUBLISHER • CH) |
| DOI | 10.3389/fpsyt.2020.00569 |
| PMID | 32733288 |
| OpenAlex | W3042112718 |
| Language | EN |
| Citations received | 9 |
| References cited | 27 |
Patients admitted to drug detoxification treatment showed multiple substance use, but this did not include NPS use. The diversion of legal medications such as pregabalin in this group is a serious concern
Alternative medicine · Cannabinoid · Cannabis · Designer drug · Detoxification (alternative medicine · Drug · Hallucinogen · Heroin · Illicit drug · MDMA · Mephedrone · Psilocybin · Psychiatry · Psychoactive drug · Psychoactive substance · Recreational Drug · Substance abuse · Synthetic cannabinoids · Forensic Toxicology and Drug Analysis · Medicine · Neurotransmitter Receptor Influence on Behavior · Psychedelics and Drug Studies
Novel Psychoactive Substances epidemic
Novel Synthetic Opioids (NSO) Use in Opioid Dependents Entering Detoxification Treatment
Knowledge and Use of Novel Psychoactive Substances in an Italian Sample with Substance Use Disorders
Synthetic Cannabinoids and Cannabis
The Role of Gabapentinoids in the Substance Use Pattern of Adult Germans Seeking Inpatient Detoxification Treatment – A Pilot Study
Availability of Illegal Drugs During the Covid-19 Pandemic in Western Germany
Synthetic cannabinoids use in a sample of opioid-use disorder patients
Synthetic cannabinoids awareness among patients with opioid use disorder in Serbia – A survey based cross-sectional pilot study
Synthetic cannabis’
How to ask about the use of new psychoactive substances to increase the validity of results in self‐report prevalence surveys
Pregabalin Abuse in Combination With Other Drugs
HCV prevalence and risk behaviours among injectors of new psychoactive substances in a risk environment in Hungary—An expanding public health burden
Emergence of Novel Psychoactive Substance injecting associated with rapid rise in the population prevalence of hepatitis C virus
| Citations per year | 1.8 |
|---|---|
| Citation span | 2021 - 2025 (5) |
| Highly cited | No |